BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 16243127)

  • 1. A randomized, double-blind, placebo-controlled trial of the combined effect of doxycycline hyclate 20-mg tablets and metronidazole 0.75% topical lotion in the treatment of rosacea.
    Sanchez J; Somolinos AL; Almodóvar PI; Webster G; Bradshaw M; Powala C
    J Am Acad Dermatol; 2005 Nov; 53(5):791-7. PubMed ID: 16243127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined effect of anti-inflammatory dose doxycycline (40-mg doxycycline, usp monohydrate controlled-release capsules) and metronidazole topical gel 1% in the treatment of rosacea.
    Fowler JF
    J Drugs Dermatol; 2007 Jun; 6(6):641-5. PubMed ID: 17668530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managing rosacea: a review of the use of metronidazole alone and in combination with oral antibiotics.
    Conde JF; Yelverton CB; Balkrishnan R; Fleischer AB; Feldman SR
    J Drugs Dermatol; 2007 May; 6(5):495-8. PubMed ID: 17679183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical metronidazole combination therapy in the clinical management of rosacea.
    Del Rosso JQ; Bikowski J
    J Drugs Dermatol; 2005; 4(4):473-80. PubMed ID: 16004021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosacea.
    Del Rosso JQ; Webster GF; Jackson M; Rendon M; Rich P; Torok H; Bradshaw M
    J Am Acad Dermatol; 2007 May; 56(5):791-802. PubMed ID: 17367893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of subantimicrobial-dose doxycycline in the treatment of moderate acne.
    Skidmore R; Kovach R; Walker C; Thomas J; Bradshaw M; Leyden J; Powala C; Ashley R
    Arch Dermatol; 2003 Apr; 139(4):459-64. PubMed ID: 12707093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Once-daily topical metronidazole cream formulations in the treatment of the papules and pustules of rosacea.
    Dahl MV; Jarratt M; Kaplan D; Tuley MR; Baker MD
    J Am Acad Dermatol; 2001 Nov; 45(5):723-30. PubMed ID: 11606923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of topical azelaic acid (AzA) gel 15% plus oral doxycycline 40 mg versus metronidazole gel 1% plus oral doxycycline 40 mg in mild-to-moderate papulopustular rosacea.
    Del Rosso JQ; Bruce S; Jarratt M; Menter A; Staedtler G
    J Drugs Dermatol; 2010 Jun; 9(6):607-13. PubMed ID: 20645521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter study of topical azelaic acid 15% gel in combination with oral doxycycline as initial therapy and azelaic acid 15% gel as maintenance monotherapy.
    Thiboutot DM; Fleischer AB; Del Rosso JQ; Rich P
    J Drugs Dermatol; 2009 Jul; 8(7):639-48. PubMed ID: 19588640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-inflamatory dose doxycycline in the treatment of rosacea.
    Del Rosso JQ
    J Drugs Dermatol; 2009 Jul; 8(7):664-8. PubMed ID: 19588643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial.
    Elewski BE; Fleischer AB; Pariser DM
    Arch Dermatol; 2003 Nov; 139(11):1444-50. PubMed ID: 14623704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness and safety of doxycycline 40 mg (30-mg immediate-release and 10-mg delayed-release beads) once daily as add-on therapy to existing topical regimens for the treatment of papulopustular rosacea: results from a community-based trial.
    Del Rosso JQ
    Cutis; 2010 Nov; 86(5 Suppl):16-25. PubMed ID: 21229827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subantimicrobial-dose doxycycline in the treatment of moderate facial acne.
    Toossi P; Farshchian M; Malekzad F; Mohtasham N; Kimyai-Asadi A
    J Drugs Dermatol; 2008 Dec; 7(12):1149-52. PubMed ID: 19137768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An update on the role of topical metronidazole in rosacea.
    Zip C
    Skin Therapy Lett; 2006 Mar; 11(2):1-4. PubMed ID: 16598386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Double-blind study versus excipient of 0.75% metronidazole gel in the treatment of rosacea].
    Espagne E; Guillaume JC; Archimbaud A; Baspeyras M; Boitier F; Bussière M; Chamberlin J; Coin A; Di Crescenzo MC; Dolivo M
    Ann Dermatol Venereol; 1993; 120(2):129-33. PubMed ID: 8240534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current topical and systemic approaches to treatment of rosacea.
    Korting HC; Schöllmann C
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):876-82. PubMed ID: 19508315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical metronidazole therapy for rosacea.
    Bleicher PA; Charles JH; Sober AJ
    Arch Dermatol; 1987 May; 123(5):609-14. PubMed ID: 2953312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of anti-inflammatory dose doxycycline versus doxycycline 100 mg in the treatment of rosacea.
    Del Rosso JQ; Schlessinger J; Werschler P
    J Drugs Dermatol; 2008 Jun; 7(6):573-6. PubMed ID: 18561589
    [No Abstract]   [Full Text] [Related]  

  • 19. Doxycycline 40 mg capsules (30 mg immediate-release/10 mg delayed-release beads): anti-inflammatory dose in rosacea.
    McKeage K; Deeks ED
    Am J Clin Dermatol; 2010; 11(3):217-22. PubMed ID: 20369903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.